Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1870 1
1871 1
1945 1
1951 2
1952 2
1954 1
1964 1
1967 1
1968 4
1969 5
1970 8
1971 15
1972 13
1973 10
1974 6
1975 10
1976 9
1977 9
1978 9
1979 8
1980 13
1981 9
1982 4
1983 8
1984 11
1985 8
1986 10
1987 15
1988 33
1989 32
1990 44
1991 53
1992 45
1993 49
1994 48
1995 38
1996 63
1997 67
1998 102
1999 90
2000 83
2001 88
2002 108
2003 100
2004 127
2005 138
2006 168
2007 167
2008 183
2009 161
2010 213
2011 265
2012 297
2013 377
2014 544
2015 745
2016 849
2017 966
2018 1217
2019 1389
2020 1572
2021 1754
2022 747
Text availability
Article attribute
Article type
Publication date

Search Results

11,506 results
Results by year
Filters applied: . Clear all
Page 1
Medical Cannabis.
Ebbert JO, Scharf EL, Hurt RT. Ebbert JO, et al. Mayo Clin Proc. 2018 Dec;93(12):1842-1847. doi: 10.1016/j.mayocp.2018.09.005. Mayo Clin Proc. 2018. PMID: 30522595 Review.
Medicolegal realities surrounding "medical marijuana" or "medical cannabis" are rapidly evolving in the United States. Clinicians are increasingly being asked by patients to share information about or certify them for medical cannabis. In …
Medicolegal realities surrounding "medical marijuana" or "medical cannabis" are rapidly evolving in the United S …
Pharmacology of Medical Cannabis.
Amin MR, Ali DW. Amin MR, et al. Adv Exp Med Biol. 2019;1162:151-165. doi: 10.1007/978-3-030-21737-2_8. Adv Exp Med Biol. 2019. PMID: 31332738 Review.
Moreover, the safety concerns regarding the unwanted side effects of delta(9)-THC as a psychoactive agent preclude its widespread use in the clinic. The legalization of cannabis for medicinal purposes and for recreational use in some regions will allow for much needed rese …
Moreover, the safety concerns regarding the unwanted side effects of delta(9)-THC as a psychoactive agent preclude its widespread use in the …
Practical considerations in medical cannabis administration and dosing.
MacCallum CA, Russo EB. MacCallum CA, et al. Eur J Intern Med. 2018 Mar;49:12-19. doi: 10.1016/j.ejim.2018.01.004. Epub 2018 Jan 4. Eur J Intern Med. 2018. PMID: 29307505 Review.
With the advent of pharmaceutical cannabis-based medicines (Sativex/nabiximols and Epidiolex), and liberalisation of access in certain nations, this ignorance of cannabis pharmacology and therapeutics has become untenable. ...Dose initiation should commence at modes …
With the advent of pharmaceutical cannabis-based medicines (Sativex/nabiximols and Epidiolex), and liberalisation of access in certai …
Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts.
Hill KP, Palastro MD. Hill KP, et al. Pol Arch Intern Med. 2017 Nov 30;127(11):785-789. doi: 10.20452/pamw.4123. Epub 2017 Oct 25. Pol Arch Intern Med. 2017. PMID: 29067992 Free article. Review.
Recently, many countries have enacted new cannabis policies, including decriminalization of cannabis possession as well as legalization of medical and recreational cannabis. ...As the number of patient requests for medical cannabis has be …
Recently, many countries have enacted new cannabis policies, including decriminalization of cannabis possession as well as leg …
Medical Cannabis for Neuropathic Pain.
Lee G, Grovey B, Furnish T, Wallace M. Lee G, et al. Curr Pain Headache Rep. 2018 Feb 1;22(1):8. doi: 10.1007/s11916-018-0658-8. Curr Pain Headache Rep. 2018. PMID: 29388063 Review.
Recent scientific discovery has elucidated the intricate role of the endocannabinoid system in the pathophysiology of neuropathic pain. As societal perceptions change, and legislation on medical cannabis relaxes, there is growing interest in the use of medical
Recent scientific discovery has elucidated the intricate role of the endocannabinoid system in the pathophysiology of neuropathic pain. As s …
Medical Cannabis: A plurimillennial history of an evergreen.
Pisanti S, Bifulco M. Pisanti S, et al. J Cell Physiol. 2019 Jun;234(6):8342-8351. doi: 10.1002/jcp.27725. Epub 2018 Nov 11. J Cell Physiol. 2019. PMID: 30417354 Review.
Its medical use is several thousand years old, as attested both by archeobotanical evidence of Cannabis remains and written records found in ancient texts from the sacred Vedic foundational texts of Ayurvedic medicine (about 800 before current era [BCE]) to the firs …
Its medical use is several thousand years old, as attested both by archeobotanical evidence of Cannabis remains and written re …
A selective review of medical cannabis in cancer pain management.
Blake A, Wan BA, Malek L, DeAngelis C, Diaz P, Lao N, Chow E, O'Hearn S. Blake A, et al. Ann Palliat Med. 2017 Dec;6(Suppl 2):S215-S222. doi: 10.21037/apm.2017.08.05. Epub 2017 Aug 23. Ann Palliat Med. 2017. PMID: 28866904 Free article. Review.
Patients who do not respond well to opioid analgesics, or have severe side effects from the use of traditional analgesics are in need of alternative therapeutic op-tions. Anecdotal evidence suggests that medical cannabis has potential to effectively manage pain in t …
Patients who do not respond well to opioid analgesics, or have severe side effects from the use of traditional analgesics are in need of alt …
Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi-Puttini P, Batticciotto A, Atzeni F, Bazzichi L, Di Franco M, Salaffi F, Marotto D, Ceribelli A, Ablin JN, Hauser W. Sarzi-Puttini P, et al. Expert Rev Clin Immunol. 2019 Oct;15(10):1019-1032. doi: 10.1080/1744666X.2019.1665997. Expert Rev Clin Immunol. 2019. PMID: 31512536 Review.
Introduction: Clinicians involved in pain management can finally include cannabis or cannabis-related products in their therapeutic armamentarium as a growing number of countries have approved them for pain relief. ...Areas covered: A review of studies carried out d …
Introduction: Clinicians involved in pain management can finally include cannabis or cannabis-related products in their therap …
Medical cannabis in the UK: From principle to practice.
Schlag AK, Baldwin DS, Barnes M, Bazire S, Coathup R, Curran HV, McShane R, Phillips LD, Singh I, Nutt DJ. Schlag AK, et al. J Psychopharmacol. 2020 Sep;34(9):931-937. doi: 10.1177/0269881120926677. Epub 2020 Jun 10. J Psychopharmacol. 2020. PMID: 32522058 Free PMC article. Review.
In marked contrast, a recent patient survey by the Centre for Medical Cannabis (Couch, 2020) found 1.4 m people are using illicit cannabis for medical problems. ...This article outlines some of the current controversies about medical cannabis
In marked contrast, a recent patient survey by the Centre for Medical Cannabis (Couch, 2020) found 1.4 m people are using illi …
Medical cannabis and mental health: A guided systematic review.
Walsh Z, Gonzalez R, Crosby K, S Thiessen M, Carroll C, Bonn-Miller MO. Walsh Z, et al. Clin Psychol Rev. 2017 Feb;51:15-29. doi: 10.1016/j.cpr.2016.10.002. Epub 2016 Oct 12. Clin Psychol Rev. 2017. PMID: 27816801 Review.
Results reflect the prominence of mental health conditions among the reasons for CTP use, and the relative dearth of high-quality evidence related to CTP in this context, thereby highlighting the need for further research into the harms and benefits of medical cannabis
Results reflect the prominence of mental health conditions among the reasons for CTP use, and the relative dearth of high-quality evidence r …
11,506 results
You have reached the last available page of results. Please see the User Guide for more information.